Morning Alertness & Beyond: An Opportunity for Bacognize®

European data consistently shows that the transition from sleep to wake represents a period of reduced alertness and cognitive efficiency, making morning cognitive readiness a highly scientifically validated optimisation window for ingredient innovation¹.

Research on Bacognize®, a clean-label, standardised extract of Bacopa monnieri, has shown improvements in morning alertness, emotional wellbeing and perceived health status, alongside further positive effects on sleep-related parameters, including reduced grogginess upon waking².

Additional findings indicate improvements in stress-related biomarkers³, supporting its role in both daytime cognitive performance and restorative sleep quality. Research also suggests that Bacognize® may interact with serotonergic pathways.

These are involved in serotonin and melatonin regulation³, supporting its role in cognitive performance, emotional stability and sleep–wake cycle regulation.

Alongside its cognitive and circadian effects, Bacognize® is also supported by a strong sustainability framework. The Sustainable Bacopa Program supports local livelihoods by employing 30–80 labourers seasonally, benefiting 50–60 families.

Furthermore, a polyhouse drying technology reduces drying time by 50% while improving yield and reducing fungal contamination through controlled drying conditions. A community farmer group manages the cultivation cycle, providing plant material, nutrients, packing and labour support, while expanded storage capacity of 250 MT helps ensure year-round supply and reduce post-harvest waste.

For more information, download the Bacognize® Product Profile Sheet here or contact us.

_{References
(1) Cassie J Hilditch & Andrew W McHill (2019) Sleep inertia: current insights, Nature and Science of Sleep, 155-165, DOI:10.2147/NSS.S188911
(2) Lopresti A et al. Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study. Journal of Functional Foods, Volume 85, October 2021, 104671.
(3) Hall et al. Pharmacology of Bacopa monnieri (Bacognize®) at 5HT1a and 5HT2a receptors. Am Soc Pharmacog Absts. 2005. 83-85. Poster presentation in 46th Am Soc Pharmacog (ASP) Annual Meeting, Corvallis, OR.}